Evidence map›Paper›PMID 35433862›Full record

ArticleFrontiers in cardiovascular medicine2022

Prognostic Power of Pulmonary Arterial Compliance Is Boosted by a Hemodynamic Unloading Test With Glyceryl Trinitrate in Heart Failure Patients With Post-capillary Pulmonary Hypertension.

Andreas J Rieth, Dimitri Grün, Georgios Zarogiannis, Steffen D Kriechbaum, Sebastian Wolter, Manuel J Richter, Khodr Tello, Ulrich Krüger, Veselin Mitrovic, Stephan Rosenkranz and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Andreas J RiethDepartment of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany.
Dimitri GrünDepartment of Internal Medicine I, Cardiology, Justus-Liebig-University Giessen, Giessen, Germany.
Georgios ZarogiannisDepartment of Cardiology, Evangelisches Klinikum Niederrhein, Duisburg, Germany.
Steffen D KriechbaumDepartment of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany.
Sebastian WolterDepartment of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany.
Manuel J RichterDepartment of Pneumology, Kerckhoff-Klinik, Bad Nauheim, Germany.
Khodr TelloDepartment of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.
Ulrich KrügerDepartment of Cardiology, Evangelisches Klinikum Niederrhein, Duisburg, Germany.
Veselin MitrovicDepartment of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany.
Stephan RosenkranzClinic III for Internal Medicine, Department of Cardiology, Heart Center at the University of Cologne and Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.
Christian W HammDepartment of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany.
Till KellerDepartment of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany.
Justus-Liebig-Universität Gießen · DEKerckhoff Klinik · DEEvangelisches Klinikum NiederrheiGerman Centre for Cardiovascular Research · DEKlinik Niederrhein · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary hypertension (PH) is an established risk factor in patients with heart failure (HF). However, right heart catheterisation (RHC) and vasoreactivity testing (VRT) are not routinely recommended in these patients. Methods: The primary objective of the present study was to explore the impact of VRT using sublingual glyceryl trinitrate (GTN) on transplant/ventricular assist device-free survival in HF patients with post-capillary PH. RHC parameters were correlated retrospectively with the primary outcome. Results: The cohort comprised 154 HF patients with post-capillary PH undergoing RHC with GTN-VRT at a tertiary heart failure centre. Multiple parameters were associated with survival. After adjustment for established prognosis-relevant clinical variables from the MAGGIC Score, variables with the most relevant odds ratios (OR) obtained after GTN-VRT were: calculated effective pulmonary arterial (PA) elastance (adjusted OR 2.26, 95%CI 1.30-3.92; Conclusions: In our cohort of symptomatic HF patients with post-capillary PH, improved PAC after administration of GTN was associated with survival independent of established hemodynamic and clinical risk factors. VRT using GTN may be better described as unloading test due to GTN's complex effects on the circulation. This could be used for advanced prognostication and should be investigated in further studies.

Indexed as

glyceryl trinitrate (GTN)hemodynamicspost-capillary pulmonary hypertensionprognosispulmonary arterial compliancevasoreactivity testing

Identifiers

PMID35433862
PMCPMC9008270
OpenAlexW4226448828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.